Welcome to Boliven.com, the leading portal for R&D, business development and IP professionals
Free & easy searching » Analyze & Download search results » Work collaboratively with colleagues » We keep you updated »
US20090233898: Pharmaceutical Compositions Comprising Simvastatin And Ezetimibe
Filing Information
| Inventor(s) | Kamal Mehta · Abhay Mahajan · Pankaj Sinde · |
| Assignee(s) |
GLENMARK GENERICS LTD ·
|
| Correspondent | GLENMARK PHARMACEUTICALS INC USA · |
| Application Number | US12400954 |
| Filing date | 03/10/2009 |
| Publication date | 09/17/2009 |
| Predicted expiration date | 03/10/2029 |
| U.S. Classifications | 514/210.02 · |
| International Classifications | A61K31397 · A61P910 · |
| Foreign Priority | IN493MUM2008 - 03/11/2008 · |
View assignee updatesAbstract
The present invention generally relates to a stable pharmaceutical composition that does not have a film coating which contains simvastatin, ezetimibe or pharmaceutically-acceptable salts thereof, and ascorbic acid.Independent Claims | See all claims (2)
- 1. A stable pharmaceutical composition that does not have a film coating comprising simvastatin and ezetimibe, or pharmaceutically acceptable salts thereof, and ascorbic acid, wherein the amount of ascorbic acid is less than 5 wt % of the final formulation.
References Cited
The current document has no citations.Referenced By
The current document is not referenced by other documents.Patent Family
The current document is not in a family.View Drawings
Interview with Ilian Iliev, CEO of CambridgeIP
In an interview with The Engineer magazine, CambridgeIP's CEO Ilian Iliev emphasised the need to engage with carbon-intensive industries in the transition to a low-carbon economy. Citing research from the recent Chatham House report 'Who Owns our Low Carbon Future?', Ilian pointed out that oil & gas companies are key owners of patented technology in this space, and have leading capabilities for CO2 injection.
